ARCHIVES

Chemosensitivity, Resistance Assays Not Ready For Clinic, ASCO Tech Assessment Says

This article is from The Cancer Letter archive.

Vol. 27 No. 8 | August 27, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief; “Sense of Urgency” In Research Is Theme of New AACR President Daniel Von Hoff

April 16, 1999

In Brief: Durant New President Of AACI, Ultmann Named President-Elect; Farber Center Gets New Name

February 4, 1983

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

July 29, 2011

On “Day One Of Post-Genome World,” Eric Lander Recounts 15-Year Journey.

February 16, 2001

Rewritten Five Year Plan For Centers Is Greeted Warmly By NCAB Committee

April 27, 1990

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001